Among the more studied immune checkpoint axes being targeted for enhanced melanoma cell killing are the cytotoxic T-lymphocyte antigen 4 (CTLA-4) axis and programmed cell death protein 1 (PD-1) with programmed death-ligand 1 (PD-L1) axis [46]. The gene discussed is PDCD1; the disease is melanoma.